These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 5577487

  • 1. Symposium on levodopa in Parkinson's disease. Clinical and pharmacological aspects. Where do we go from here?
    Clin Pharmacol Ther; 1971; 12(2):408-16. PubMed ID: 5577487
    [No Abstract] [Full Text] [Related]

  • 2. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
    Andrews CJ, Somerville B.
    Med J Aust; 1974 Mar 23; 1(12):429-32. PubMed ID: 4598384
    [No Abstract] [Full Text] [Related]

  • 3. [Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor].
    Christiani K, Möller WD.
    Munch Med Wochenschr; 1973 Apr 20; 115(16):711-3. PubMed ID: 4197759
    [No Abstract] [Full Text] [Related]

  • 4. Symposium on levodopa in Parkinson's disease. Clinical and pharmacological aspects. Introduction.
    McDowell F.
    Clin Pharmacol Ther; 1971 Apr 20; 12(2):317-8. PubMed ID: 5577479
    [No Abstract] [Full Text] [Related]

  • 5. [Dopa and decarboxylase inhibitors in Parkinson's disease].
    Pakkenberg H.
    Ugeskr Laeger; 1974 Feb 11; 136(7):377. PubMed ID: 4821980
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of Parkinson's disease with levodopa and Ro 4-4602.
    Barbeau A, Gillo-Joffroy L, Mars H.
    Clin Pharmacol Ther; 1971 Feb 11; 12(2):353-9. PubMed ID: 4930866
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MK 486 and levodopa in treatment of Parkinsonism.
    Lieberman AN, Derby BM, Feigenson J, Goodgold A, Nesbitte J, Resurreccion EC, Valdivia F.
    Dis Nerv Syst; 1973 Feb 11; 34(4):167-71. PubMed ID: 4711885
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study].
    Tissot R, de Ajuriaguerra J.
    Nouv Presse Med; 1973 Feb 03; 2(5):315-6. PubMed ID: 4686226
    [No Abstract] [Full Text] [Related]

  • 13. Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease.
    Sweet RD, Lee JE, McDowell F.
    Trans Am Neurol Assoc; 1971 Feb 03; 96():59-65. PubMed ID: 5159130
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Levodopa (Larodopa). For the relief of symptoms associated with Parkinson's disease and syndrome.
    Clin Pharmacol Ther; 1970 Feb 03; 11(6):921-4. PubMed ID: 4921295
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of Parkinson's disease with levodopa].
    Sigwald J, Raymondeaud C, Grégoire J.
    Therapeutique; 1972 Nov 03; 48(9):543-54. PubMed ID: 4650524
    [No Abstract] [Full Text] [Related]

  • 17. Reappraisal of levodopa therapy for Parkinson's disease. A three-year experience with outpatients in private practice.
    McFarland HR.
    Mo Med; 1974 Sep 03; 71(9):535-7. PubMed ID: 4854038
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.